Fig. 3.

The concordance between the results of the C6 ELISA and the results of the SERION ELISA (a) and the concordance between the results of the C6 ELISA plus immunoblot strategy and the SERION ELISA plus immunoblot strategy (b). HI: healthy individuals; THI: treated healthy individuals; TNB: treated Lyme neuroborreliosis patients; ANB: active Lyme neuroborreliosis patients; n: number of study subjects. Only statistical significant differences are displayed. For all two-group comparisons with a significant difference, the Bonferroni correction was applied (p: 0.050/6 = 0.008). */#: Significant difference between the ELISAs (*) and the test strategies (#) in the overall dataset; **: Significant difference between the two-group comparisons of the ELISAs